Taylor - Martino - Kuykendall Attorneys At LawReputation, Experience & Dedication

Home
Firm Overview
Attorneys
Practice Areas
Cases
Community Involvement
Contact Us


Car AccidentsTruck AccidentsPharmaceutical Liability
 
Hot Topics

Clinical Consequences of Enterobacter sakazakii Infections

John Alexander, M.D., M.P.H.
Division of Anti-Infective Drug Products,
Center for Drug Evaluation and Research, FDA

Outline

  • Neonatal Meningitis
  • Necrotizing Enterocolitis
  • Bacteremia/Sepsis

Neonatal Meningitis

  • Incidence: 0.25-1/1000 Live Births
  • Usual Pathogens:
    • Group B Streptococcus
    • Escherichia coli
    • Listeria monocytogenes
  • Enterobacter spp. < 4% of One Survey
    • Rare Organism in a Rare Disease

Neonatal Meningitis

  • Clinical Manifestations
    • Non-Specific Findings
      • Fever/Temperature Instability
      • Lethargy/Poor Feeding
      • Respiratory Distress
    • Specific Findings (Infrequent)
      • Bulging Fontanelle
      • Stiff Neck/Opisthotonus
      • Convulsions

Neonatal Meningitis

  • E. sakazakii
    • Based on Collected Literature
    • 55% of Neonates < 2500g
    • 50% of Pediatric Cases < 1 Week of Age
    • Almost 75% < 1 Month of Age

Lai KK, Medicine 2001; 80(2):113-22

Burdette et al., Pediatric Radiology
(2000) 30:33-34

Neonatal Meningitis

  • Outcome
    • 17% Case Fatality Rate for Gram (-) Meningitis
    • 45% for E. sakazakii Meningitis from Reports
  • Therapy
    • At least 3 weeks of IV Antibiotics
    • Longer for Persistent (+) Cultures

Neonatal Meningitis

  • Sequelae of Gram (-) Meningitis in 58%
    • Developmental Delay (37%)
    • Seizure Disorder (36%)
    • Cerebral Palsy (31%)
    • Hydrocephalus (27%)
    • Hearing Loss (17%)

Unhanand M et al., J Pediatrics 1993; 122(1): 15-21

Necrotizing Enterocolitis

  • Disease of the GI Tract
  • Mostly in Pre-Term Infants
    • Approximately 10% of Affected Infants are Term Infants*
    • Up to 10% of NICU Admissions*
  • Multifactorial Disease
  • Outbreak - Association with Infection

*Fanaroff and Martin: Neonatal-Perinatal Medicine, 7th edition, 2002.

Necrotizing Enterocolitis

  • Bacteria
    • Coagulase-Negative Staphylococci, Escherichia coli (including ETEC), Enterobacter spp., Klebsiella spp., Pseudomonas aeruginosa, Salmonella spp., Clostridium difficile, Clostridium perfringens, Clostridium butyricum
  • Viruses
    • Rotavirus, Coronavirus

Principles and Practice of Pediatric Infectious Diseases

Necrotizing Enterocolitis

  • Clinical Manifestations
    • Wide Spectrum of Disease
    • Sudden or Insidious Onset
    • Non-Specific Findings
      • Feeding intolerance, Temperature instability, Lethargy, Apnea, Respiratory Distress, Metabolic Acidosis, Glucose instability, Leukocytosis, Neutropenia, Thrombocytopenia, Shock
    • GI Findings
      • Abdominal distention, tenderness and/or erythema, Bilious emesis, Blood in stools (Visible or Microscopic), Disorganized bowel gas pattern, Pneumatosis Intestinalis, Portal Venous Gas, Pneumoperitoneum, Peritoneal Ascites

Necrotizing Enterocolitis

  • Therapy
    • Discontinue Feedings/Nasogastric Decompression
    • Serial Radiographic Examinations
    • Blood Culture and Antibiotics
    • IV Fluids/Supportive Care for Systemic Disease
    • Surgery for Advanced Disease (Roughly 20%)

Necrotizing Enterocolitis

  • Outcomes
    • Overall Mortality Rates due to NEC in Last Decade: 9-28% *
    • Survival 98% for Medical Management
    • Surgical Mortality Rate 45% ** (range up to 60%) *
      • Inversely Related to Gestational Age and Size
    • GI strictures 25%-35%, after Medical or Surgical Therapy *
    • GI Dysfunction (10%)
    • Neurodevelopmental Sequelae (15-33%)
    • Short Gut Syndrome

* Fanaroff and Martin: Neonatal-Perinatal Medicine, 7th edition, 2002.
** Grosfeld JL et al., J Pediatr Surg 1998 July;33(7):967-72

Bacteremia/Sepsis

  • Bacteremia - Bacteria in the Blood
    • Occurs with Many Infections
  • Meningitis and NEC
  • Sepsis - Clinical Syndrome
    • Shock, Fever, Systemic Illness
    • Associated with Morbidity and Mortality

Bacteremia/Sepsis

  • Opportunistic Pathogen
    • Neonate/Prematurity
      • Meningitis and NEC Cases;
      • 7 d/o with Fever/Sepsis; Hospitalized
    • Cancer/Central Line
      • 3 y/o Rhabdomyosarcoma; Recovered with Antibiotics and Line Removal
    • Altered Host Defense
      • 6 m/o Intestinal Resection; Recovered with Abx

Conclusions

  • Enterobacter sakazakii
    • Cause of Meningitis, NEC, Bacteremia
    • Serious Morbidity and Mortality
      • Especially in Neonatal Disease

Office Locations



Alabama Law Office Florida Law Office
51 St. Joseph Street 216 Palafox Place
P.O. Box 894 P.O. Box 12305
Mobile, AL 36601 Pensacola, FL 32502